Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Pfizer Inc. boosts its oncology pipeline with strategic control of PD-1/VEGF bispecific drugs via 3SBio deal. Click for more ...

Pfizer’s stock surged up to 11 percent after the pharma giant reported a robust 85 percent year-on-year rise in net profit ...

There are instances where high-yielding stocks can simply be great deals. Three stocks that pay at least 6% and don't look ...

These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains ...

Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.

The stock jumped 11.91% during the day to touch a high of Rs 4,995.85 on the stock exchanges, after starting the day at Rs ...

According to Benzinga Pro, Pfizer's peer group average for short interest as a percentage of float is 3.60%, which means the ...

Pfizer shares climbed Tuesday after two punchy headlines hit the wire. FDA advisors are considering COVID-19 vaccines for ...

The declines in these stocks reflect the overall market dynamics and sector-specific challenges faced by these companies ...